Info

The Longevity & Biohacking Show with Jason Hartman & Fernando Aires

A show created to inform listeners on the important aspects of health, wealth and happiness to ensure you live life to its fullest. Your host, Jason Hartman, interviews top notch authors and gurus in the field to reveal expert advice. Guest include: Dr. Charles Tandy, David Ewing Duncan, Dr. Joseph Maroon, Dr. Edmund Chein, Dr. Michael Mosley, Matt Fitzgerald, Dr. Norman Shealy, Ari Tulla, Budge Collinson, Luis Tijerina, Ben Greenfield, Dr. Brett Osborn, Ted Anton, Patrick Cox, Jenny Craig, and many more.
RSS Feed
The Longevity & Biohacking Show with Jason Hartman & Fernando Aires
2018
August
July
June
April
March
February
January


2017
December
November
October
September
August
July
June
May
April
March
February
January


2016
December
November
October
September
August
July
June
May
April
March
February
January


2015
December
November
October
September
August
July
June
May
April
March
February
January


2014
December


Categories

All Episodes
Archives
Categories
Now displaying: Page 1
Jun 29, 2017

Brian Hanley is the founder of Butterfly Science, and his mission is simple: he wants to develop gene therapies to help fight HIV and aging. Fernando Aires and Brian discuss what Brian's research has shown him in the fight against aging, as well as what amazing possibilities we have when it comes to changing human characteristics for the better.

Key Takeaways:

[3:16] How Butterfly Sciences is going to change things with their products

[7:32] If there's a limit to how long you can have your body continue keeping up with the GH levels

[10:30] Brian's business model and whether his products are available to the public now (or when they will be)

[12:47] How Brian's therapy can be used for HIV/AIDS

[16:18] What Brian's HIV therapy timeline is

[19:04] What the future holds for longevity and therapies that could help travelers to Mars and potential humans with Marvel-like capabilities

Website:

www.bf-sci.com

www.ieet.org

0 Comments
Adding comments is not available at this time.